AUG 31, 2016 08:59 AM PDT

Salmonella School Scientists on How to Thwart Cancer

WRITTEN BY: Xuan Pham
Cancer cells know when they’re being attacked. And one of their best counterattack strategies is to pump the chemotherapy drugs out of their cells. Now researchers at the University of Massachusetts Medical School say they can potentially thwart cancer’s defenses with nanoparticles that mimic the bacterium Salmonella.  

On the surface of some cancer cells, membrane proteins called P-glycoprotein (P-gp) act like funnel chutes that rid the cells of any toxins. This is bad news for cancer patients, as the presence of these proteins on cancer cells can compromise the efficacy of chemotherapy treatments.

Serendipitously, researchers noted that Salmonella – the bacteria that’s notorious for food poisonings – appear to reduce the level of P-gp in cells. "While trying to understand how Salmonella invades the human host, we made this other observation that may be relevant to cancer therapeutics and multidrug resistance," said Beth McCormick, lead study author.

Could they co-opt the bacteria’s strategy and ultimately reduce chemotherapy resistance? Indeed, through several experiments, McCormicks’ team identified a key protein in Salmonella that seemed to influence the level of P-gp. That protein is known as SipA. In cell cultures, adding SipA alone was enough to reduce P-pg membrane proteins in human colon cancer, breast cancer, bladder cancer, and lymphoma. This, in combination with chemotherapy drugs, showed that the cancer cells were more susceptible to the anticancer treatment and were less able to expel the drugs out of their system.

"Through millions of years of co-evolution, Salmonella has figured out a way to remove this transporter from the surface of intestinal cells to facilitate host infection," said Dr. McCormick. "We capitalized on the organism's ability to perform that function."
 

But, it is not possible to treat cancer by infecting people with Salmonella. Nor is it feasible to administer SipA as a single molecule agent, as this compound is unstable in the bloodstream. Therefore, the team went with the next best thing and combined their knowledge with nanotechnology – that is, they created gold nanoparticles that are fused with SipA.

In preliminary cellular experiments, the nanoparticles proved to be 100 times more effective than SipA alone in lowering P-gp levels. Furthermore, in mouse models of colon cancer and breast cancer, combining traditional chemotherapy with the nanoparticles resulted in slower and smaller tumor growths. This indicates the SipA nanoparticles act to boost the anticancer effects of the chemotherapy.

As encouraging as these results are, the team is still wary about other possible side effects of reducing P-gp in the entire system. Since P-gp is actually a way for normal cells to stay healthy, interfering with this mechanism could produce drastic unwanted side effects.  "We are not naïve about the complexity of the problem," said McCormick. "However, if we know more about the biology, we believe we can ultimately make a better drug."

Additional sources: National Cancer Institute
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 19, 2018
Earth & The Environment
JUN 19, 2018
Does Roundup cause cancer?
Monsanto has long been the scary monster lurking in the closet, with its seed-patenting and fertilizer-pushing. Now the first case actually bringing the co...
JUL 03, 2018
Cancer
JUL 03, 2018
Hereditary Myeloid Neoplasm Predisposition
New changes in myeloid classification help to outline a new category of AML which develops as a result of hereditary mutations predisposing family members to myeloid neoplasms in adulthood....
JUL 13, 2018
Genetics & Genomics
JUL 13, 2018
Detecting Leukemia Before it Starts Growing
Researchers have found ways to identify people who may develop an aggressive type of blood cancer while they are still healthy....
AUG 14, 2018
Cancer
AUG 14, 2018
Using Arsenic to Enhance Cancer Therapies Beyond Leukemia
An already existing combination of arsenic and all-trans retinoic acid is found to inhibit a key signaling pathway that exerts broad effect on oncogenic processes for some solid tumors....
AUG 15, 2018
Cancer
AUG 15, 2018
Cancer Control Headway in The Last 20 Years
Learning from history and what changes have been made will continue to help drive cancer controls for the future....
OCT 17, 2018
Cell & Molecular Biology
OCT 17, 2018
Saving Patients From Unnecessary Chemotherapy with a Blood Test
Often, cancer patients get chemotherapy after surgery to ensure that their cancer will not come back; for many it's not needed....
Loading Comments...